A potential role for creatine in drug abuse?

Molecular Neurobiology

Volumn 44, Issue 2, 2011, Pages 136-141

  D'Anci, Kristen E ^a   Allen, Patricia J ^a   Kanarek, Robin B ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Creatine; Depression; Drug abuse; Magnetic resonance spectroscopy; Nutrition; Post traumatic stress disorder; Stress; Traumatic brain injury

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE;

AMINO ACID SYNTHESIS; ARTICLE; CLINICAL ASSESSMENT; DEPRESSION; DIETARY INTAKE; DRUG ABUSE; DRUG DEPENDENCE; DRUG SYNTHESIS; HUMAN; NEUROPROTECTION; NONHUMAN; SUPPLEMENTATION; TRAUMATIC BRAIN INJURY;

EID: 80054851979     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8176-2     Document Type: Article

References (69)

1. RH Andres, et al. 2008 Functions and effects of creatine in the central nervous system Brain Res Bull 76 4 329 343 18502307 10.1016/j.brainresbull.2008. 02.035 1:CAS:528:DC%2BD1cXmtlWht70%3D
2. B Gualano, et al. 2010 Exploring the therapeutic role of creatine supplementation Amino Acids 38 1 31 44 19253023 10.1007/s00726-009-0263-6 1:CAS:528:DC%2BC3cXhtVehtLs%3D
3. PJ Allen, et al. 2010 Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner Neuropsychopharmacology 35 2 534 546 19829292 10.1038/npp.2009.160 1:CAS:528:DC%2BD1MXhsFGmsrjE
4. D Amital, et al. 2006 Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder J Clin Psychiatry 67 5 836 837 16841637 10.4088/JCP.v67n0521c (Pubitemid 43946195)
5. S Roitman, et al. 2007 Creatine monohydrate in resistant depression: a preliminary study Bipolar Disord 9 7 754 758 17988366 10.1111/j.1399-5618.2007. 00532.x 1:CAS:528:DC%2BD1cXisVKq (Pubitemid 350042411)
6. E Beard O Braissant 2010 Synthesis and transport of creatine in the CNS: importance for cerebral functions J Neurochem 115 2 297 313 20796169 10.1111/j.1471-4159.2010.06935.x 1:CAS:528:DC%2BC3cXhtleqtr3E
7. M Wyss R Kaddurah-Daouk 2000 Creatine and creatinine metabolism Physiol Rev 80 3 1107 1213 10893433 1:CAS:528:DC%2BD3cXlsFWjsb8%3D (Pubitemid 30452013)
8. M Wyss T Wallimann 1994 Creatine metabolism and the consequences of creatine depletion in muscle Mol Cell Biochem 133-134 51 66 7808465 10.1007/BF01267947 (Pubitemid 24276825)
9. SH Mudd, et al. 2007 Methyl balance and transmethylation fluxes in humans Am J Clin Nutr 85 1 19 25 17209172 1:CAS:528:DC%2BD2sXmvFehug%3D%3D (Pubitemid 46067610)
10. IK Lyoo, et al. 2003 Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate Psychiatry Res 123 2 87 100 12850248 10.1016/S0925-4927(03)00046-5 1:CAS:528:DC%2BD3sXmsFOgurs%3D (Pubitemid 36794575)
11. JT Brosnan ME Brosnan 2007 Creatine: endogenous metabolite, dietary, and therapeutic supplement Annu Rev Nutr 27 241 261 17430086 10.1146/annurev.nutr. 27.061406.093621 1:CAS:528:DC%2BD2sXhsVWisL3E (Pubitemid 351373357)
12. MJ McLeish GL Kenyon 2005 Relating structure to mechanism in creatine kinase Crit Rev Biochem Mol Biol 40 1 1 20 15804623 10.1080/10409230590918577 1:CAS:528:DC%2BD2MXisl2ku7Y%3D (Pubitemid 40446303)
13. T Wallimann, et al. 1992 Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis Biochem J 281 Pt 1 21 40 1731757 1:CAS:528:DyaK38XjvVCjsA%3D%3D
14. F Niklasson H Agren 1984 Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood Biol Psychiatry 19 8 1183 1206 6498242 1:CAS:528:DyaL2MXktFaj (Pubitemid 14014782)
15. EV Kuzhikandathil GR Molloy 1994 Transcription of the brain creatine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase J Neurosci Res 39 1 70 82 7528818 10.1002/jnr.490390110 1:CAS:528: DyaK2cXmtVWnurs%3D (Pubitemid 24286537)
16. B Wilken, et al. 1998 Creatine protects the central respiratory network of mammals under anoxic conditions Pediatr Res 43 1 8 14 9432106 10.1203/00006450-199801000-00002 1:CAS:528:DyaK1cXjtlOitw%3D%3D (Pubitemid 28069161)
17. RH Andres, et al. 2005 Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue J Neurochem 95 1 33 45 16045451 10.1111/j.1471-4159.2005.03337.x 1:CAS:528:DC%2BD2MXhtVygs7bJ (Pubitemid 41384423)
18. RH Andres, et al. 2005 Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system Cell Transplant 14 8 537 550 16355565 10.3727/000000005783982756 (Pubitemid 41739258)
19. RH Andres, et al. 2005 Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue Neuroscience 133 3 701 713 15890457 10.1016/j.neuroscience.2005.03.004 1:CAS:528: DC%2BD2MXltFWis78%3D (Pubitemid 40798323)
20. AD Ducray, et al. 2007 Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord J Neurosci Res 85 9 1863 1875 17526013 10.1002/jnr.21337 1:CAS:528:DC%2BD2sXot1Onurc%3D (Pubitemid 47051475)
21. PF Renshaw, et al. 2001 Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression Am J Psychiatry 158 12 2048 2055 11729024 10.1176/appi.ajp.158.12.2048 1:STN:280:DC%2BD3Mnot1aksA%3D%3D (Pubitemid 33104113)
22. GT Rezin, et al. 2009 Mitochondrial dysfunction and psychiatric disorders Neurochem Res 34 6 1021 1029 18979198 10.1007/s11064-008-9865-8 1:CAS:528:DC%2BD1cXhtlWhtbvL
23. L Shao, et al. 2008 Mitochondrial involvement in psychiatric disorders Ann Med 40 4 281 295 18428021 10.1080/07853890801923753 1:CAS:528: DC%2BD1cXltFCmtLY%3D (Pubitemid 351563935)
24. N Brustovetsky T Brustovetsky JM Dubinsky 2001 On the mechanisms of neuroprotection by creatine and phosphocreatine J Neurochem 76 2 425 434 11208905 10.1046/j.1471-4159.2001.00052.x 1:CAS:528:DC%2BD3MXhtVGkt7o%3D (Pubitemid 32097020)
25. RT Matthews, et al. 1998 Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease J Neurosci 18 1 156 163 9412496 1:CAS:528:DyaK1cXjtVKqtg%3D%3D (Pubitemid 28046777)
26. RT Matthews, et al. 1999 Creatine and cyclocreatine attenuate MPTP neurotoxicity Exp Neurol 157 1 142 149 10222117 10.1006/exnr.1999.7049 1:CAS:528:DyaK1MXis1Klurk%3D (Pubitemid 29226877)
27. BD Roy, et al. 2002 Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats Can J Physiol Pharmacol 80 10 1008 1014 12450068 10.1139/y02-129 1:CAS:528: DC%2BD38XovValtrk%3D (Pubitemid 35408541)
28. IK Lyoo PF Renshaw 2002 Magnetic resonance spectroscopy: current and future applications in psychiatric research Biol Psychiatry 51 3 195 207 11839362 10.1016/S0006-3223(01)01313-0 (Pubitemid 34142631)
29. H Agren F Niklasson 1988 Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note J Neural Transm 74 1 55 59 3171573 10.1007/BF01243575 1:STN:280:DyaL1M%2FhtVOnuw%3D%3D
30. B Czeh, et al. 2001 Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine Proc Natl Acad Sci USA 98 22 12796 12801 11675510 10.1073/pnas.211427898 1:CAS:528:DC%2BD3MXotFahs7c%3D (Pubitemid 33020024)
31. DV Iosifescu, et al. 2008 Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder Biol Psychiatry 63 12 1127 1134 18206856 10.1016/j.biopsych.2007.11.020 1:CAS:528: DC%2BD1cXmsFOjtLw%3D
32. CM Moore, et al. 1997 Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study Am J Psychiatry 154 1 116 118 8988971 1:STN:280: DyaK2s7kt12lsg%3D%3D (Pubitemid 27020205)
33. HP Volz, et al. 1998 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients Eur Arch Psychiatry Clin Neurosci 248 6 289 295 9928907 10.1007/s004060050052 1:STN:280:DyaK1M7isF2rtQ%3D%3D (Pubitemid 29026984)
34. SR Dager, et al. 2004 Brain metabolic alterations in medication-free patients with bipolar disorder Arch Gen Psychiatry 61 5 450 458 15123489 10.1001/archpsyc.61.5.450 1:CAS:528:DC%2BD2cXkslektbg%3D (Pubitemid 38620843)
35. M Segal, et al. 2007 Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients Eur Neuropsychopharmacol 17 3 194 198 17049435 10.1016/j.euroneuro.2006.08.010 1:CAS:528:DC%2BD28Xht1eqsLvO (Pubitemid 44779200)
36. T Kato, et al. 1992 Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy J Affect Disord 26 4 223 230 1479134 10.1016/0165-0327(92)90099-R 1:STN:280:DyaK3s7itlKgtg%3D%3D
37. T Kato, et al. 1994 Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy J Affect Disord 31 2 125 133 8071475 10.1016/0165-0327(94)90116-3 1:STN:280: DyaK2czltFWisQ%3D%3D (Pubitemid 24183900)
38. MS Gold, et al. 2009 Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates Biol Psychiatry 66 2 118 127 19345341 10.1016/j.biopsych.2009.02.021 1:CAS:528: DC%2BD1MXnvVantr8%3D
39. SC Licata PF Renshaw 2010 Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction Ann N Y Acad Sci. 1187 148 171 20201852 10.1111/j.1749-6632.2009.05143.x 1:CAS:528:DC%2BC3cXks1Smsr4%3D
40. G Sakellaris, et al. 2006 Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study J Trauma 61 2 322 329 16917445 10.1097/01.ta.0000230269.46108.d5 1:STN:280:DC%2BD28rhtlOgtw%3D%3D (Pubitemid 44265811)
41. G Sakellaris, et al. 2008 Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study Acta Paediatr 97 1 31 34 18053002 10.1111/j.1651-2227.2007.00529.x 1:CAS:528:DC%2BD1cXhsFems7rK
42. PG Sullivan, et al. 2000 Dietary supplement creatine protects against traumatic brain injury Ann Neurol 48 5 723 729 11079535 10.1002/1531- 8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W 1:CAS:528:DC%2BD3cXosFSgt7w%3D
43. SW Scheff HS Dhillon 2004 Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury Neurochem Res 29 2 469 479 15002746 10.1023/B:NERE.0000013753.22615.59 1:CAS:528:DC%2BD2cXosFGhsQ%3D%3D (Pubitemid 38223031)
44. S Zhu, et al. 2004 Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice J Neurosci 24 26 5909 5912 15229238 10.1523/JNEUROSCI.1278-04.2004 1:CAS:528:DC%2BD2cXlsleltLs%3D (Pubitemid 38859388)
45. J Daumann, et al. 2004 Proton magnetic resonance spectroscopy in ecstasy (MDMA) users Neurosci Lett 362 2 113 116 15193766 10.1016/j.neulet.2004.03.004 1:CAS:528:DC%2BD2cXktlCqsLY%3D (Pubitemid 38759080)
46. L Reneman, et al. 2001 Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report Biol Psychiatry 50 7 550 554 11600108 10.1016/S0006-3223(01)01177-5 1:CAS:528:DC%2BD3MXntlOqsLs%3D (Pubitemid 32971886)
47. R Salo, et al. 2007 Attentional control and brain metabolite levels in methamphetamine abusers Biol Psychiatry 61 11 1272 1280 17097074 10.1016/j.biopsych.2006.07.031 1:CAS:528:DC%2BD2sXls1aju7k%3D (Pubitemid 46726259)
48. D Hermann, et al. 2007 Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users Biol Psychiatry 61 11 1281 1289 17239356 10.1016/j.biopsych.2006.08.027 1:CAS:528:DC%2BD2sXls1aju7c%3D (Pubitemid 46726261)
49. J O'Neill VA Cardenas DJ Meyerhoff 2001 Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging Addict Biol 6 4 347 361 11900613 10.1080/13556210020077073 (Pubitemid 32946750)
50. J O'Neill VA Cardenas DJ Meyerhoff 2001 Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse Alcohol Clin Exp Res 25 11 1673 1682 11707642 10.1111/j.1530-0277.2001.tb02174.x (Pubitemid 33104930)
51. S Yang, et al. 2009 Lower glutamate levels in rostral anterior cingulate of chronic cocaine users-a (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy Psychiatry Res 174 3 171 176 19906515 10.1016/j.pscychresns.2009.05.004 1:CAS:528:DC%2BD1MXhsVGms7bP
52. W Adriani, et al. 2007 1 H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence Neurotoxicol Teratol 29 1 116 125 17196789 10.1016/j.ntt.2006.11.010 1:CAS:528:DC%2BD2sXhs1Slsrg%3D (Pubitemid 46205168)
53. T Ernst, et al. 2000 Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1 H MRS study Neurology 54 6 1344 1349 10746608 1:STN:280:DC%2BD3cvgs1Cluw%3D%3D (Pubitemid 30174057)
54. L Chang, et al. 1999 Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users Am J Psychiatry 156 5 716 722 10327904 1:STN:280:DyaK1M3lvFyrug%3D%3D (Pubitemid 29220069)
55. LM Smith, et al. 2001 Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero Pediatrics 107 2 227 231 11158451 10.1542/peds.107.2.227 1:STN:280:DC%2BD3M3msFWjsA%3D%3D (Pubitemid 32121234)
56. A Buttner 2011 Review: the neuropathology of drug abuse Neuropathol Appl Neurobiol 37 2 118 134 20946118 10.1111/j.1365-2990.2010.01131.x 1:STN:280:DC%2BC3M%2Fps1OrsA%3D%3D
57. AP Silva, et al. 2010 Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier Curr Drug Abuse Rev 3 4 239 254 21208167 10.2174/1874473711003040239 1:CAS:528: DC%2BC3MXjsFWlsLw%3D
58. P Dechent, et al. 1999 Increase of total creatine in human brain after oral supplementation of creatine-monohydrate Am J Physiol 277 3 Pt 2 R698 R704 10484486 1:CAS:528:DyaK1MXmt1Gju7w%3D
59. SR Nash, et al. 1994 Cloning, pharmacological characterization, and genomic localization of the human creatine transporter Recept Channels 2 2 165 174 7953292 1:CAS:528:DyaK2MXhtlChu70%3D (Pubitemid 24262703)
60. S Ohtsuki, et al. 2002 The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain J Cereb Blood Flow Metab 22 11 1327 1335 12439290 10.1097/00004647-200211000-00006 1:CAS:528: DC%2BD38Xosl2gtrc%3D (Pubitemid 35285090)
61. JW Pan K Takahashi 2007 Cerebral energetic effects of creatine supplementation in humans Am J Physiol Regul Integr Comp Physiol 292 4 R1745 R1750 17185404 10.1152/ajpregu.00717.2006 1:CAS:528:DC%2BD2sXks1Kitb0%3D (Pubitemid 46557801)
62. P Sestili, et al. 2006 Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity Free Radic Biol Med 40 5 837 849 16520236 10.1016/j.freeradbiomed.2005.10.035 1:CAS:528:DC%2BD28XitVartrg%3D (Pubitemid 43327318)
63. PM Abou-Sleiman MM Muqit NW Wood 2006 Expanding insights of mitochondrial dysfunction in Parkinson's disease Nat Rev Neurosci 7 3 207 219 16495942 10.1038/nrn1868 1:CAS:528:DC%2BD28Xhs1Gqt70%3D (Pubitemid 43292466)
64. J Kim, et al. 2010 Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease Biochim Biophys Acta 1802 7-8 673 681 20460152 1:CAS:528:DC%2BC3cXnvVyjs7s%3D
65. EC Stack WR Matson RJ Ferrante 2008 Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants Ann NY Acad Sci 1147 79 92 19076433 10.1196/annals.1427.008 1:CAS:528:DC%2BD1MXhsVaqtbo%3D
66. Zhang, S.F., et al. (2011) Impaired brain creatine kinase activity in Huntington's disease. Neurodegener Dis. doi: 10.1159/000321681
67. A Bender, et al. 2005 Creatine supplementation lowers brain glutamate levels in Huntington's disease J Neurol 252 1 36 41 15672208 10.1007/s00415-005-0595-4 1:CAS:528:DC%2BD2MXpslWgu7k%3D (Pubitemid 40179016)
68. SM Hersch, et al. 2006 Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG Neurology 66 2 250 252 16434666 10.1212/01.wnl.0000194318.74946.b6 1:CAS:528:DC%2BD28XpsFGj (Pubitemid 43970166)
69. A Bender, et al. 2006 Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial Neurology 67 7 1262 1264 17030762 10.1212/01.wnl.0000238518.34389.12 1:CAS:528:DC%2BD28XhtFyqtLfF (Pubitemid 44563840)